Skip to main content
. 2022 Apr;14(2):138–144. doi: 10.18502/ijm.v14i2.9178

Table 1.

Seroprevalence of SARS-CoV-2–specific IgG antibodies in HCWs in the Valiasr Hospital of Birjand, Iran

No. (%)of participants Seroprevalence (95% CI), % P value
Overall 180 24.4% (18.2–30.7) P=0.03
Sex Male 69 (38.3) 12.8 (7.9–17.7)
Female 111 (61.7) 11.7 (7–16.4)
Age, y ≤30 72 (40) 9.1 (4.8–13.3) P=0.24
31–40 61 (33.9) 6.3 (2.7–9.8)
≥41 47 (26.1) 8.6 (4.5–12.7)
Location Village 177 (98.3) 22.5 (16.4–28.6) P=0.002
Town 3 (1.7) 1.7 (0–3.6)
Underlying disease Yes 15 (8.3) 1.7 (0–3.6) P=0.68
No 165 (91.7) 22.8 (16.7–28.9)
Family member with Yes 62 (34.4) 13.2 (8.2–18.1) P=0.002
COVID-19 No 118 (65.6) 10.9 (6.3–15.4)
Occupation Physician 32 (17.8) 3.9 (1.1–6.7) P=0.004
Nurse 60 (33.3) 9.4 (5.1–13.7)
Laboratory technician 34 (18.9) 2.2 (0–4.3)
Hospital service workers 38 (21.1) 8.9 (4.7–13)
Administrative staff 16 (8.9) 0 (0–0)
Area of care Infectious diseases 49 (27.2) 10 (5.6–14.4) P=0.09
Hospital emergency 32 (17.8) 5.6 (2.2–8.9)
Intensive care unit 13 (7.2) 1.1 (0–2.6)
Internal ward 11 (6.1) 2.2 (0–4.3)
Pediatric ward 14 (7.8) 0.6 (0–1.7)
Radiology 3 (1.7) 0.6 (0–1.7)
Laboratory 39 (21.7) 3.3 (0.6–5.9)
Administrative department 19 (10.5) 1.1 (0–2.6)
Working hours (week) ≤45 96 (53.3) 11.3 (6.7–15.9) P=0.58
≥45 84 (46.7) 12.8 (7.9–17.7)
Night shift (month) ≤ 2 93 (51.7) 13.3 (8.3–18.3) P=0.19
3–6 77 (42.8) 10.9 (6.3–15.4)
≥7 10 (5.5) 3.1 (0–5.6)
Work experience ≤2 35 (19.4) 4.1 (1.2–7) P=0.98
3–10 67 (37.2) 8.9 (4.7–13)
11–20 55 (30.6) 7.5 (3.6–11.3)
≥21 23 (12.8) 2.7 (0.3–5.1)
Occupational stress Yes 104 (57.8) 13.2 (8.2–18.1) P=0.62
No 76 (42.2) 10.9 (6.3–15.4)